SANTÉ INVESTS AT THE LEADING EDGE OF INNOVATION IN HEALTHCARE AND TECHNOLOGY. WE MANAGE APPROXIMATELY ONE BILLION DOLLARS OF CAPITAL IN TWO SEPARATE STRATEGIES.
Privately Held Companies
Santé Ventures invests in innovative new healthcare companies, with a particular focus in Biotech, Medtech, and Healthtech.
Publicly Traded Securities
Santé Capital applies state-of-the-art data science and machine learning technologies to generate attractive risk-adjusted returns in a systematic liquid strategy.
02 Santé Ventures Strategy
We search the emerging technology landscape for visionary entrepreneurs and innovative new ideas with the potential to deliver better patient health outcomes through advances in biology, medicine, and information.
03 Santé Capital Strategy
We leverage the latest advances in big data, machine learning, and natural language processing to systematically capture investment opportunities in a liquid portfolio of mispriced publicly traded securities.
04 NewsroomSee All News
Santé’s Jason Brandt Named to List of Top 101 U.S.…
July 5, 2022
CNBC: Investors see growth opportunity in Femtech devoted to women’s…
March 21, 2022
Lumos Pharma CEO Update: Interview with Lumos Pharma’s Chief Medical Officer, David B. Karpf, M.D.
July 27, 2022
HNI Healthcare’s VitalsMD® Software Achieves HITRUST Risk-based, 2-year Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements
July 19, 2022